• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入速尿对人体二氧化碳通气反应性的影响。

Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans.

作者信息

Minowa Y, Ide T, Nishino T

机构信息

Department of Anesthesiology, Graduate School of Medicine, Chiba University, 1-8-1 Inohanacho, chuo-ku, Chiba 260-8670, Japan.

出版信息

Pulm Pharmacol Ther. 2002;15(4):363-8. doi: 10.1006/pupt.2002.0376.

DOI:10.1006/pupt.2002.0376
PMID:12220941
Abstract

We previously showed that inhaled furosemide improves experimentally induced dyspnea. In order to test the possibility that inhaled furosemide may alter the CO(2) chemosensitivity and thereby reduce the dyspneic sensation, the effect of inhaled furosemide on CO(2) chemosensitivity was evaluated with a double-blinded, randomized crossover design in 10 healthy subjects. The CO(2) chemosensitivity was measured by the steady-state and rebreathing methods before and after the inhalation of placebo (normal saline) and furosemide aerosols (40 mg). In addition, subjects were asked to rate their sensation of respiratory discomfort using a visual analog scale (dyspneic VAS) during the measurement of CO(2) chemosensitivity with the steady-state method. Our results showed that (1) inhaled furosemide does not affect the breathing patterns of resting breathing, (2) inhaled furosemide does not affect the slope and intercept of the CO(2) response curve, regardless of whether the CO(2) chemosensitivity is measured by the steady-state technique or rebreathing technique and (3) inhaled furosemide improves the dyspneic sensation produced during hypercapnic hyperpnea. These results suggest that the mechanism of the improvement of dyspnea by inhaling furosemide is not associated with the decrease in the ventilatory drive to CO(2).

摘要

我们之前表明吸入速尿可改善实验性诱发的呼吸困难。为了测试吸入速尿可能改变二氧化碳化学敏感性从而减轻呼吸困难感觉的可能性,我们采用双盲、随机交叉设计,在10名健康受试者中评估了吸入速尿对二氧化碳化学敏感性的影响。在吸入安慰剂(生理盐水)和速尿气雾剂(40毫克)前后,通过稳态法和重复呼吸法测量二氧化碳化学敏感性。此外,在使用稳态法测量二氧化碳化学敏感性期间,要求受试者使用视觉模拟量表(呼吸困难视觉模拟量表)对其呼吸不适感觉进行评分。我们的结果表明:(1)吸入速尿不影响静息呼吸的呼吸模式;(2)无论通过稳态技术还是重复呼吸技术测量二氧化碳化学敏感性,吸入速尿均不影响二氧化碳反应曲线的斜率和截距;(3)吸入速尿可改善高碳酸血症性通气过度期间产生的呼吸困难感觉。这些结果表明,吸入速尿改善呼吸困难的机制与对二氧化碳的通气驱动降低无关。

相似文献

1
Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans.吸入速尿对人体二氧化碳通气反应性的影响。
Pulm Pharmacol Ther. 2002;15(4):363-8. doi: 10.1006/pupt.2002.0376.
2
Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea.吸入速尿能极大地缓解实验诱导的呼吸困难感。
Am J Respir Crit Care Med. 2000 Jun;161(6):1963-7. doi: 10.1164/ajrccm.161.6.9910009.
3
Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease.吸入性速尿对慢性阻塞性肺疾病运动性呼吸困难的影响。
Am J Respir Crit Care Med. 2004 May 1;169(9):1028-33. doi: 10.1164/rccm.200308-1171OC. Epub 2004 Feb 20.
4
Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial.吸入呋塞米缓解气促与呼吸费力感:一项随机对照试验。
Respir Res. 2018 Sep 20;19(1):181. doi: 10.1186/s12931-018-0886-9.
5
Effect of inhaled furosemide on air hunger induced in healthy humans.吸入性速尿对健康人诱发的空气饥饿的影响。
Respir Physiol Neurobiol. 2007 Apr 16;156(1):1-8. doi: 10.1016/j.resp.2006.07.004. Epub 2006 Aug 28.
6
THAM improves an experimentally induced severe dyspnea.三羟甲基氨基甲烷可改善实验诱导的严重呼吸困难。
J Pain Symptom Manage. 2009 Feb;37(2):212-9. doi: 10.1016/j.jpainsymman.2008.02.017. Epub 2008 Sep 19.
7
Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure.二氢可待因对慢性心力衰竭患者化疗敏感性和运动耐量的影响。
J Am Coll Cardiol. 1997 Jan;29(1):147-52. doi: 10.1016/s0735-1097(96)00446-9.
8
Inhaled furosemide does not alleviate respiratory effort during flow-limited exercise in healthy subjects.
Pulm Pharmacol Ther. 2008;21(1):196-200. doi: 10.1016/j.pupt.2007.02.003. Epub 2007 Mar 6.
9
The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.健康志愿者对胆囊收缩素四肽的通气反应。
Neuropsychopharmacology. 2002 Jun;26(6):824-31. doi: 10.1016/S0893-133X(02)00283-X.
10
Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation.特发性通气过度时对吸入二氧化碳、低氧和运动的通气反应
Am J Respir Crit Care Med. 2004 Jul 15;170(2):118-25. doi: 10.1164/rccm.200207-720OC. Epub 2004 Apr 1.

引用本文的文献

1
Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial.慢性阻塞性肺疾病(COPD)患者联合使用雾化速尿和沙丁胺醇与单药治疗的对比:一项随机对照试验
Ann Med Surg (Lond). 2020 Jul 18;57:85-90. doi: 10.1016/j.amsu.2020.07.005. eCollection 2020 Sep.
2
Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men.吸入雾化速尿(40毫克和120毫克)对健康男性在存在胸廓外部限制时运动期间呼吸困难的影响。
Front Physiol. 2018 Feb 12;9:86. doi: 10.3389/fphys.2018.00086. eCollection 2018.
3
Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.
雾化吸入速尿治疗呼吸困难:控制给药并不能提高疗效。
Respir Physiol Neurobiol. 2018 Jan;247:146-155. doi: 10.1016/j.resp.2017.10.002. Epub 2017 Oct 12.
4
The symptomatic relief of dyspnea.呼吸困难的症状缓解。
Curr Oncol Rep. 2008 Jul;10(4):319-25. doi: 10.1007/s11912-008-0050-7.